NOX2-derived ROS-mediated surface translocation of BLT1 is essential for exocytosis in human eosinophils induced by LTB 4

International Archives of Allergy and Immunology

Volumn 165, Issue 1, 2014, Pages 40-51

  Min, Arim ^a   Lee, Young Ah ^a   Kim, Kyeong Ah ^a   El Benna, Jamel ^b   Shin, Myeong Heon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CNRS   (France)

Author keywords

BLT1 surface trafficking; Exocytosis; Human eosinophils; Leukotriene B 4; Reactive oxygen species

Indexed keywords

ANTIBODY; CD63 ANTIGEN; LEUKOTRIENE B4; P2Y7 ANTIBODY; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SRC KINASE INHIBITOR; UNCLASSIFIED DRUG; CD63 PROTEIN, HUMAN; CYBB PROTEIN, HUMAN; LEUKOTRIENE B4 RECEPTOR; LTB4R PROTEIN, HUMAN; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BLOOD; CELL SURFACE; CONTROLLED STUDY; EOSINOPHIL; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PHOSPHORYLATION; PROTEIN EXPRESSION; UPREGULATION; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOLOGY; INFLAMMATION; METABOLISM; MONONUCLEAR CELL;

ANTIGENS, CD63; EOSINOPHILS; EXOCYTOSIS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE B4; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, LEUKOTRIENE B4;

EID: 84908309666     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000366277     Document Type: Article

References (67)

1. Miyahara N, Ohnishi H, Matsuda H, Miyahara S, Takeda K, Koya T, Matsubara S, Okamoto M, Dakhama A, Haribabu B, Gelfand EW: Leukotriene B 4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness. J Immunol 2008; 181: 1170-1178.
2. Wan M, Sabirsh A, Wetterholm A, Agerberth B, Haeggstrom JZ: Leukotriene B 4 triggers release of the cathelicidin LL-37 from human neutrophils: Novel lipid-peptide interactions in innate immune responses. FASEB J 2007; 21: 2897-2905.
3. Costa MF, de Souza-Martins R, de Souza MC, Benjamim CF, Piva B, Diaz BL, Peters-Golden M, Henriques MG, Canetti C, Penido C: Leukotriene B 4 mediates ?d T lymphocyte migration in response to diverse stimuli. J Leukoc Biol 2010; 87: 323-332.
4. Kim EY, Seo JM, Kim C, Lee JE, Lee KM, Kim JH: BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway. Free Radic Biol Med 2010; 49: 1072-1081.
5. Iikura M, Suzukawa M, Yamaguchi M, Sekiya T, Komiya A, Yoshimura-Uchiyama C, Nagase H, Matsushima K, Yamamoto K, Hirai K: 5-Lipoxygenase products regulate basophil functions: 5-oxo-ETE elicits migration, and leukotriene B 4 induces degranulation. J Allergy Clin Immunol 2005; 116: 578-585.
6. Nam YH, Min D, Kim HP, Song KJ, Kim KA, Lee YA, Kim SH, Shin MH: Leukotriene B 4 receptor BLT-mediated phosphorylation of NF-?B and CREB is involved in IL-8 production in human mast cells induced by Trichomonas vaginalis -derived secretory products. Microbes Infect 2011; 13: 1211-1220.
7. Terawaki K, Yokomizo T, Nagase T, Toda A, Taniguchi M, Hashizume K, Yagi T, Shimizu T: Absence of leukotriene B 4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J Immunol 2005; 175: 4217-4225.
8. Huang L, Zhao A, Wong F, Ayala JM, Struthers M, Ujjainwalla F, Wright SD, Springer MS, Evans J, Cui J: Leukotriene B 4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler Thromb Vasc Biol 2004; 24: 1783-1788.
9. Flamand L, Tremblay MJ, Borgeat P: Leukotriene B 4 triggers the in vitro and in vivo release of potent antimicrobial agents. J Immunol 2007; 178: 8036-8045.
10. Lundeen KA, Sun B, Karlsson L, Fourie AM: Leukotriene B 4 receptors BLT1 and BLT2: Expression and function in human and murine mast cells. J Immunol 2006: 177: 3439-3447.
11. Tager AM, Luster AD: BLT1 and BLT2: The leukotriene B 4 receptors. Prostaglandins Leukot Essent Fatty Acids 2003: 69; 123-134.
12. Miyahara N, Miyahara S, Takeda K, Gelfand EW: Role of the LTB 4 /BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol Int 2006; 55: 91-97.
13. Watanabe S, Yamasaki A, Hashimoto K, Shigeoka Y, Chikumi H, Hasegawa Y, Sumikawa T, Takata M, Okazaki R, Watanabe M, Yokogawa T, Yamamura M, Hayabuchi T, Gerthoffer WT, Halayko AJ, Shimizu E: Expression of functional leukotriene B 4 receptors on human airway smooth muscle cells. J Allergy Clin Immunol 2009; 124: 59-65.
14. Ohnishi H, Miyahara N, Gelfand EW: The role of leukotriene B 4 in allergic diseases. Allergol Int 2008; 57: 291-298.
15. Sanchez-Galan E, Gomez-Hernandez A, Vidal C, Martin-Ventura JL, Blanco-Colio LM, Munoz-Garcia B, Ortega L, Egido J, Tunon J: Leukotriene B 4 enhances the activity of nuclear factor-?B pathway through BLT1 and BLT2 receptors in atherosclerosis. Cardiovasc Res 2009; 81: 216-225.
16. Kim ND, Chou RC, Seung E, Tager AM, Luster AD: A unique requirement for the leukotriene B 4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med 2006; 203: 829-835.
17. Spite M, Hellmann J, Tang Y, Mathis SP, Kosuri M, Bhatnagar A, Jala VR, Haribabu B: Deficiency of the leukotriene B 4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. J Immunol 2011; 187: 1942-1949.
18. Chwiesko-Minarowska S, Kowal K, Bielecki M, Kowal-Bielecka O: The role of leukotrienes in the pathogenesis of systemic sclerosis. Folia Histochem Cytobiol 2012; 50: 19348.
19. Kita H: Eosinophils multifaceted biological properties and roles in health and disease. Immunol Rev 2011; 242: 161-177.
20. Carlos D, Machado ER, De Paula L, Sa-Nunes A, Sorgi CA, Jamur MC, Oliver C, Lima WT, Faccioli LH: Evidence for eosinophil recruitment, leukotriene B 4 production and mast cell hyperplasia following Toxocara canis infection in rats. Braz J Med Biol Res 2011; 44: 319-326.
21. Muraki M, Imbe S, Santo H, Sato R, Sano H, Iwanaga T, Tohda Y: Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Int Arch Allergy Immunol 2011; 155: 90-95.
22. Hosoki K, Nakamura A, Nagao M, Hiraguchi Y, Tanida H, Tokuda R, Wada H, Nobori T, Suga S, Fujisawa T: Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor. J Leukoc Biol 2012; 92: 333-341.
23. Rose CE Jr, Lannigan JA, Kim P, Lee JJ, Fu SM, Sung SS: Murine lung eosinophil activation and chemokine production in allergic airway inflammation. Cell Mol Immunol 2012; 7: 361-374.
24. Garro AP, Chiapello LS, Baronetti JL, Masih DT: Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4 + and CD8 + T cells with a T-helper 1 profile. Immunology 2011; 132: 174-187.
25. Kampe M, Lampinen M, Stolt I, Janson C, Stalenheim G, Carlson M: PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model. Inflammation 2012; 35: 230-239.
26. Melo RC, Spencer LA, Dvorak AM, Weller PF: Mechanisms of eosinophil secretion: Large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. J Leukoc Biol 2008; 83: 229-236.
27. Logan MR, Lacy P, Bablitz B, Moqbel R: Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. J Allergy Clin Immunol 2002; 109: 299-306.
28. Melo RC, Spencer LA, Perez SA, Neves JS, Bafford SP, Morgan ES, Dvorak AM, Weller PF: Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. Lab Invest 2009; 89: 769-781.
29. Melo RC, Spencer LA, Perez SA, Ghiran I, Dvorak AM, Weller PF: Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic 2005; 6: 1047-1057.
30. Hartmann J, Scepek S, Hafez I, Lindau M: Differential regulation of exocytotic fusion and granule-granule fusion in eosinophils by Ca 2+ and GTP analogs. J Biol Chem 2003; 278: 44929-44934.
31. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT: Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation. J Immunol 1991; 147: 3466-3473.
32. Barlic J, Andrews JD, Kelvin AA, Bosinger SE, DeVries ME, Xu L, Dobransky T, Feldman RD, Ferguson SS, Kelvin DJ: Regulation of tyrosine kinase activation and granule release through ß-arrestin by CXCRI. Nat Immunol 2000; 1: 227-233.
33. Ng CF, Sun FF, Taylor BM, Wolin MS, Wong PY: Functional properties of guinea pig eosinophil leukotriene B 4 receptor. J Immunol 1991; 147: 3096-3103.
34. Manea A: NADPH oxidase-derived reactive oxygen species: Involvement in vascular physiology and pathology. Cell Tissue Res 2010; 342: 325-339.
35. Kim GY, Lee JW, Ryu HC, Wei JD, Seong CM, Kim JH: Proinflammatory cytokine IL-1ß stimulates IL-8 synthesis in mast cells via a leukotriene B 4 receptor 2-linked pathway, contributing to angiogenesis. J Immunol 2010; 184: 3946-3954.
36. Seo JM, Cho KJ, Kim EY, Choi MH, Chung BC, Kim JH: Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Exp Mol Med 2011; 43: 129-137.
37. Bylund J, Brown KL, Movitz C, Dahlgren C, Karlsson A: Intracellular generation of superoxide by the phagocyte NADPH oxidase: How, where, and what for? Free Radic Biol Med 2010; 49: 1834-1845.
38. Yoon J, Terada A, Kita H: CD66b regulates adhesion and activation of human eosinophils. J Immunol 2007; 179: 8454-8462.
39. Petheo GL, Orient A, Barath M, Kovacs I, Rethi B, Lanyi A, Rajki A, Rajnavolgyi E, Geiszt M: Molecular and functional characterization of Hv1 proton channel in human granulocytes. PLoS One 2010; 23: E14081.
40. Seo JM, Cho KJ, Kim EY, Choi MH, Chung BC, Kim JH: Up-regulation of BLT2 is critical for the survival of bladder cancer cells. Exp Mol Med 2011; 43: 129-137.
41. Chetram MA, Don-Salu-Hewage AS, Hinton CV: ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells. Biochem Biophys Res Commun 2011; 410: 195-200.
42. Souvannakitti D, Nanduri J, Yuan G, Kumar GK, Fox AP, Prabhakar NR: NADPH oxidase-dependent regulation of T-type Ca 2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells. J Neurosci 2010; 30: 10763-10772.
43. Johansson AS, Haeggstrom JZ, Hultenby K, Palmblad J: Subcellular localization of leukotriene receptors in human endothelial cells. Exp Cell Res 2010; 316: 2790-2796.
44. Neves JS, Radke AL, Weller PF: Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. J Allergy Clin Immunol 2010; 125: 477-482.
45. Qiu H, Johansson AS, Sjostrom M, Wan M, Schroder O, Palmblad J, Haeggstrom JZ: Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B 4 . Proc Natl Acad Sci USA 2006; 103: 6913-6918.
46. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1a-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997; 186: 139-146.
47. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD: Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010; 29: 4599-4610.
48. Otero C, Eisele PS, Schaeuble K, Groettrup M, Legler DF: Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis. J Cell Sci 2008; 121: 2759-2767.
49. Del Prete A, Shao WH, Mitola S, Santoro G, Sozzani S, Haribabu B: Regulation of dendritic cell migration and adaptive immune response by leukotriene B 4 receptors: A role for LTB 4 in up-regulation of CCR7 expression and function. Blood 2007; 109: 626-631.
50. Toyomitsu E, Tsuda M, Yamashita T, Tozaki-Saitoh H, Tanaka Y, Inoue K: CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia. Purinergic Signal 2012; 8: 301-310.
51. Dikalov S: Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 2011; 51: 1289-1301.
52. Serezani CH, Perrela JH, Russo M, Peters-Golden M, Jancar S: Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J Immunol 2006; 177: 3201-3208.
53. Raad H, Paclet MH, Boussetta T, Kroviarski Y, Morel F, Quinn MT, Gougerot-Pocidalo MA, Dang PM, El-Benna J: Regulation of the phagocyte NADPH oxidase activity: Phosphorylation of gp91 phox /NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67 phox , and p47 phox . FASEB J 2009; 23: 1011-1022.
54. Lee JH, Kim JW, Kim do K, Kim HS, Park HJ, Park DK, Kim AR, Kim B, Beaven MA, Park KL, Kim YM, Choi WS: The Src family kinase Fgr is critical for activation of mast cells and IgE-mediated anaphylaxis in mice. J Immunol 2011; 187: 1807-1815.
55. Mancuso P, Lewis C, Serezani CH, Goel D, Peters-Golden M: Intrapulmonary administration of leukotriene B 4 enhances pulmonary host defense against pneumococcal pneumonia . Infect Immun 2010; 78: 2264-2271.
56. Serezani CH, Aronoff DM, Jancar S, Peters-Golden M: Leukotriene B 4 mediates p47 phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils. J Leukoc Biol 2005; 78: 976-984.
57. Serezani CH, Aronoff DM, Sitrin RG, Peters-Golden M: FceRI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions. Blood 2009; 114: 3316-3324.
58. RaoMalla R, Raghu H, Rao JS: Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells. Int J Oncol 2010; 37: 1483-1493.
59. Salaun C, James DJ, Chamberlain LH: Lipid rafts and the regulation of exocytosis. Traffic 2004; 5: 255-264.
60. Puri N, Roche PA: Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic 2006; 7: 1482-1494.
61. Salaun C, Gould GW, Chamberlain LH: Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J Biol Chem 2005; 280: 19449-19453.
62. Hornef MW, Normark BH, Vandewalle A, Normark S: Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003; 198: 1225-1235.
63. Uriarte SM, Rane MJ, Luerman GC, Barati MT, Ward RA, Nauseef WM, McLeish KR: Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. J Immunol 2011; 187: 391-400.
64. Huang YS, Chiang NY, Hu CH, Hsiao CC, Cheng KF, Tsai WP, Yona S, Stacey M, Gordon S, Chang GW, Lin HH: Activation of myeloid cell-specific adhesion class G proteincoupled receptor EMR2 via ligation-induced translocation and interaction of receptor subunits in lipid raft microdomains. Mol Cell Biol 2012; 32: 1408-1420.
65. Oakley FD, Smith RL, Engelhardt JF: Lipid rafts and caveolin-1 coordinate interleukin-1ß (IL-1ß) -dependent activation of NF-?B by controlling endocytosis of Nox2 and IL-1ß receptor 1 from the plasma membrane. J Biol Chem 2009; 284: 33255-33264.
66. Wu M, Baumgart T, Hammond S, Holowka D, Baird B: Differential targeting of secretory lysosomes and recycling endosomes in mast cells revealed by patterned antigen arrays. J Cell Sci 2007; 120: 3147-3154.
67. MacGlashan DW Jr: Endocytosis, recycling, and degradation of unoccupied Fc?RI in human basophils. J Leukoc Biol 2007; 82: 1003-1010.